HRTX

Heron Therapeutics (HRTX)

About Heron Therapeutics (HRTX)

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.

Details

Daily high

$1.28

Daily low

$1.19

Price at open

$1.22

52 Week High

$2.68

52 Week Low

$1.00

Market cap

221.9M

Dividend yield

0.00%

Volume

1.1M

Avg. volume

1.5M

P/E ratio

-14.96

Heron Therapeutics News